Study investigators sought to determine if galcanezumab would reduce not only the frequency of migraine days but also the disabling nonpain symptoms of episodic and chronic migraine.
Your search for major depressive disorder returned 3 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Various migraine subgroups based on comorbidities can predict the risk for the progression of episodic migraine to chronic migraine.
The presence of psychiatric disorders in patients with idiopathic intracranial hypertension is associated with poor treatment outcomes.